Solicitation, total small business set-aside
Phase I - Serological Assays for the detection and characterization of influenza viruses
75D30125R73211_Phase_I
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
November 21, 2024 at 2:00 PM EST
Closed 665 days ago. Posted November 14, 2024. Scheduled to archive April 28, 2025.
Description
As published on SAM.gov.
The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
November 14, 2024
Solicitation, originally presolicitation
Due November 21, 2024 at 2:00 PM EST. SAM.gov, notice 9b7ce42c9dbe49d7b0d808b6f8712ffd
Points of contact
- Jennifer Gartzkejgartzke@cdc.gov4044980020
Also open from this buyer
- Flyability Elios 3 Surveying LiDAR DroneSolicitationNAICS 336411Pittsburgh, PA75D301-26-Q-79289Closes tomorrowSep 18
- Systematic Information ReviewCombined synopsis and solicitationSmall businessNAICS 541990Atlanta, GA75D301-26-Q-79261Closes tomorrowSep 18
- Electronic Key Box SystemSolicitationSmall businessNAICS 561621Georgia75D301-26-R-73515Closes tomorrowSep 18
- Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance AgreementPresolicitationNAICS 811210Georgia2026-95987Closes in 98 daysDec 24